Empresa Cancer Prevention Pharmaceuticals Inc
Acciones
CPP
US13740W1071
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Eugene W. Gerner
FOU | Founder | 76 | 09/06/08 |
Jeffrey Jacob
CEO | Chief Executive Officer | 62 | 09/06/08 |
Alfred M. Cohen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | - | |
Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jon Saxe
BRD | Director/Board Member | 88 | 23/07/15 |
Richard L. Love
BRD | Director/Board Member | 81 | 01/11/11 |
Jeffrey Jacob
CEO | Chief Executive Officer | 62 | 09/06/08 |
Eugene W. Gerner
FOU | Founder | 76 | 09/06/08 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 6 759 443 | 4 226 504 ( 62,53 %) | 0 | 62,53 % |
Información de la empresa
Cancer Prevention Pharmaceuticals, Inc.
1760 East River Road Suite 250
85718, Tucson
+520 908 7774
http://www.canprevent.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+8,63 % | 115 mil M | |
+13,17 % | 107 mil M | |
-12,76 % | 22,31 mil M | |
-3,99 % | 21,6 mil M | |
-7,19 % | 18,23 mil M | |
-39,93 % | 17,62 mil M | |
+6,67 % | 14,26 mil M | |
+33,90 % | 12,37 mil M | |
-28,60 % | 8281,14 M |